Jennifer Rodney, MD
Otolaryngology · Dallas, TXNPI 1164784591
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,465 of the $3,698 with a category attached, or 93.7%. Teleflex LLC accounts for 93.7% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $3,465, more than ten times the $30 reported in 2019.
Across 11 payments — averaging $336.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$3K
- Merck$96
- Acclarent, Inc$85
- Olympus America Inc.$36
- AstraZeneca$12
- Ambu Inc.$4
What the payments were for
- Speaking & faculty fees$3,46594%
- Food & beverage$2336%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 1 | $3,465 |
| Merck | 2 | $96 |
| Acclarent, Inc | 4 | $85 |
| Olympus America Inc. | 2 | $36 |
| AstraZeneca | 1 | $12 |
| Ambu Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PILLING$3,465
How this compares
$3,698 in reported general payments places this provider in the 70th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 57 | $1,029 |
| Ipratropium Bromide | 28 | $853 |
| Fluticasone Propionate | 28 | $485 |
| Nystatin | 14 | $362 |
| Gabapentin | 14 | $324 |
| Pantoprazole Sodium | 13 | $315 |
| Fluconazole | 17 | $202 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $179 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $162 |
| Amitriptyline Hcl | 16 | $151 |
| Famotidine | 11 | $126 |
| Tramadol Hcl | 23 | $61 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dallas
- Rajiv PanditDallas$71K
- Naren VenkatesanDallas$35K
- Michael MedinaDallas$19K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.